Long-Term Study Of The Safety Of Tanezumab In Arthritis Patients

NCT00960804 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
21
Enrollment
INDUSTRY
Sponsor class

Stopped See termination reason in detailed description.

Conditions

Interventions

Sponsor

Pfizer